OClawVPS.com
MindMaze SA
Edit

MindMaze SA

http://www.mindmaze.com/
Last activity: 24.03.2026
Active
Categories: 3DGamingMedTechProductTechnologyTimeTrainingVirtual
MindMaze combines immersive virtual reality, brain imaging and 3D technology in real time to build novel platforms for Neurorehabilitation, Game Training and 3D Imaging. Our neurotechnology products enable tailored interfaces matching the user’s abilities across different applications.
Mentions
69
Location: Switzerland, Vaud, Lausanne
Total raised: $330M

Investors 3

Funding Rounds 3

DateSeriesAmountInvestors
17.02.2022-$105M-
12.10.2021-$125M-
17.02.2016-$100M-

Mentions in press and media 69

DateTitleDescription
24.03.2026New Climate VC VitaminC Raises $20 million Global climate tech funding has slowed, valuations have reset, and many generalist funds have deprioritized the sector. VitaminºC views this market dislocation as a defining opportunity to invest at more attractive valuations with stronger...
17.02.2026From Ideas to IPO: The structured path behind Switzerland’s next listed companies17.02.2026 14:00, Markus Hammer Switzerland’s strongest deeptech startups share more than scientific excellence. They share a development journey that systematically transforms early-stage innovation into globally competitive companies. Wha...
04.02.2026Swiss Startups Defy Global Headwinds, Secure Billions in Landmark Funding YearSwiss startups delivered a stunning performance in 2025. They defied a volatile global economy and sluggish growth. Venture capital funding surged to nearly CHF 3 billion across 354 rounds. This marked the first significant increase since 2...
03.02.2026Massiv mehr Geld für Schweizer Startups Die weltpolitische Lage ist instabil, die Wirtschaft wächst nur wenig und die exportierenden Branchen leiden unter unsicheren Aussichten. Das Umfeld war 2025 alles andere als günstig. Trotzdem floss erstmals seit 2022 wieder mehr Geld in S...
03.02.2026CHF 2.9 billion for Swiss startups in 202503.02.2026 09:29, Rita Longobardi Investment in Swiss hightech startups rose by 23.9% to CHF 2.9 billion in 2025, according to Swiss Venture Capital Report, published by the online news portal startupticker.ch and the industry association S...
03.02.2026Hausse massive des fonds pour les startups suisses La situation politique mondiale est instable, la croissance économique est faible et les secteurs exportateurs souffrent de perspectives incertaines. En 2025, le contexte était tout sauf favorable. Néanmoins, pour la première fois depuis 2...
03.02.2026Significantly more money for Swiss start-ups The global political situation is unstable, economic growth is sluggish and export-oriented industries are suffering from uncertain prospects. The environment in 2025 was anything but favourable. Nevertheless, for the first time since 2022...
08.10.2025NeuroX, successor to MindMaze, joins Relief Therapeutics to form SIX-listed company NeuroX's clinically validated digital neurotherapeutic suite is currently deployed in over 250 clinics and rehabilitation centers globally. Its solutions are supported by a unique U.S. Category III reimbursement code (CAT-3), enabling scal...
04.09.202515 Years of Top100: Corintis tops the ranks The Top100 Swiss Startup Ranking showcases the 100 Swiss startups with the most significant potential. Each year, a jury of 100 startup investors selects the most promising companies that are no older than five years after incorporation. W...
30.07.2025NeuroX enters business combination agreement with Relief Therapeutics Based in Geneva, Relief Therapeutics is a commercial-stage biopharmaceutical company dedicated to advancing treatment paradigms and improving the lives of patients with rare and debilitating diseases. With core expertise in drug delivery s...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In